CSIMarket
 



Intersect Ent Inc   (XENT)
Other Ticker:  
 
 



 

What are Intersect Ent Inc's Business Segments?



Intersect ENT Inc. is a medical device company that specializes in developing innovative solutions for ear, nose, and throat (ENT) disorders. Their products and services can be categorized into the following segments:

1. Drug Delivery: Intersect ENT offers a range of drug delivery systems for the treatment of chronic sinusitis. Their flagship product is PROPELe sinus stent, a bioabsorbable implant that keeps the sinuses open after surgery and delivers a controlled dose of steroids to reduce inflammation. Other products in this segment include PROPELe Contour sinus stent, SINUVAe sinus implant, and NOVAPAKe personalized sinus balloon. These products are designed to improve patient outcomes by reducing the need for additional surgeries and systemic steroids.

2. Navigation: Intersect ENT also provides a navigation system for ENT surgeons called the SINUVAe Navigation System. This technology uses real-time imaging to provide surgeons with a detailed view of the surgical site, helping them to navigate complex anatomy and achieve precise placement of implants. This system can be used in conjunction with other Intersect ENT products, such as the SINUVAe sinus implant.

3. Diagnostics: Intersect ENT offers a wide range of diagnostic tools for ENT physicians, including the ASCENDe Video Endoscope System and the NOVAFORMe sinus balloon catheter. These tools are used to visualize and access the nasal and sinus cavities, allowing for accurate diagnosis and treatment of ENT disorders.

4. Services: Intersect ENT provides a range of services to support their products, including training and education for physicians, clinical support, and reimbursement assistance. They also offer patient education materials and support to help patients better understand their conditions and treatment options.

In summary, Intersect ENT Inc. offers a comprehensive range of products and services for the treatment of ENT disorders. Their innovative drug delivery systems, navigation technology, and diagnostic tools are designed to improve patient outcomes and reduce the need for additional surgeries and systemic steroids. Their commitment to education and support ensures that patients and physicians have access to the resources they need to make informed decisions about treatment.
   

Intersect Ent Inc Tax Rate Companies within the Medical Equipment & Supplies Industry


Business Segments Q1
Revenues
(in millions $)
Q1
Income
(in millions $)
(Mar 31 2022)
%
(Profit Margin)
Total 21.58 -57.61 -

Growth rates by Segment Q1
Y/Y Revenue
%
(Mar 31 2022)
Q/Q Revenue
%
Q1
Y/Y Income
%
(Mar 31 2022)
Q/Q Income
%
Total -11.32 % -29.66 % - -

To get more information on Intersect Ent Inc's Total segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com